Incannex

Australian Cannabis Index | DEA Grants Research Growing Approvals

At the same time, it was also announced that the Minnesota state government had successfully passed a proposal to legalize recreational marijuana use.Last week the US government an...

Australian Cannabis Index | SAFE Act Passage Prompts Rebound from HMMJ

Conversely, the Australian Cannabis Index underperformed again last week, as investors turned their attention towards the US cannabis market.The US cannabis market reacted in jubil...

Australian Cannabis Index | Is the US Cannabis Bubble About to Burst?

Although the HMMJ recorded an impressive 91% gain on the month prior, this was a significant decline from the ETF's position earlier in February, when it achieved an 183% gain at t...

Incannex Healthcare Releases Positive Results from In Vivo Brain Injury Study

This could be huge news, as TBI is responsible for roughly "10 million deaths and/or hospitalizations" globally each year, and there are currently no registered pharmaceutical agen...

Will Betting Big on Coronavirus Lead to a Rebound for the Australian Cannabis Index?

We're taking an in depth look at some of the ASX-listed shares that have driven the market forward over the last week. The Australian cannabis market has continued to expand at ara...

Study Finds Cannabis May Help With COVID-19

Researchers from the University of South Carolina performed studies on mice with COVID-19, that suggest THC may help to mitigate the harmful impacts of the virus. As the world cont...

Incannex Testing the Potential of a Hydroxychloroquine-Cannabidiol Formulation

Incannex recently announced positive results for their hydroxychloroquine-cannabidiol formulation, which can potentially treat the inflammatory conditions associated with COVID-19....

These Two ASX-Listed Cannabis Biotechs are Working on a COVID-19 Treatment

As the COVID-19 pandemic stretches on, many companies are vying to come up with a treatment - including two ASX-listed cannabis companies. Throughout the world, over 25 million cas...

Incannex Enters Into Medicinal Cannabis Oil Supply Agreement

Impression Healthcare's Incannex Pharmaceuticals has entered into a supply agreement to research and formulate four new cannabinoid drugs. Impression Health (ASX:IHL) has officiall...

Impression Healthcare Just Seriously Upped The Ante

Impression Healthcare's (ASX: IHL) Chief Medical Officer Dr. Sud Agarwal recently gave a speech on the company's annual general meeting. Here's everything you need to know. Impress...